A phase I clinical trial assessing prophylactic infusion of donor CD45RA-negative memory - effector T cells into patients transplanted with hematopoietic stem cells from haploidentical donors after reduced intensity conditioning

The first TANDEM grant call received 28 applications from clinician-basic researcher pairs across Switzerland, each jointly addressing a question of…

See our Annual Report 2021 !

The ISREC Foundation has been promoting cancer research since 1964. The work accomplished by the supported scientists over the past decades has led to…

As part of her “Hans Tuppy Lecture” at the University of Vienna, attended by Prof. Tuppy himself, an interview was conducted with Prof. Susan Gasser.…